Home Top Movers Is Check Cap Ltd (CHEK) Stock a buy now?

Is Check Cap Ltd (CHEK) Stock a buy now?

Things have started to change for Check Cap since the NASDAQ compliance re-gain extension. 

The clinical-stage medical diagnostics company shares are trading with strong momentum. The average trading volume of Check-Cap Ltd. (CHEK) is just over 8 million. As we write this on Jan 5., the trading volume is almost 235 million. Is it a good time to jump in and buy the stock?


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


What going on?

Check-Cap Ltd. (CHEK) stock is skyrocketing, but what’s the exact reason? On Dec. 30, 2020, the company received a notice of a 180-day extension to regain NASDAQ compliance. This allows the stocks to have enough time to trade above the $1 minimum required share price on the market. 

This NASDAQ compliance extension has driven high volume over the past week. Investors are now seeing things in a positive way as the company tries to fight back.

Back in Nov. 2020, the company announced that it had submitted the Investigational Device Exemption (IDE) application to the FDS for its pivotal study of C-Scan. The IDE is a great achievement towards the initiation of the pivotal study in the U.S. The company is expected to provide updates on its C-Scan study in the near future, following the guidance from the FDA. 

Moreover, the company is preparing well at the backend for the U.S. pivotal study; improving the supply chain, quality controls, and device manufacturing. The company is also managing the expansion of this study at the leading Israeli sites. 

The core objective of Check-Cap is to advance its C-Scan towards the final cynical stages and make it to the market. The C-Scan is being developed as a patient-friendly colorectal cancer (CRC) screening option—detecting pre-cancerous polyps. The company expects a response from the FDA anytime soon.

However, on the other side of the picture, there are concerns regarding Check-Cap’s cash balance. As of Sep. 2020, the company had cash of $21 million with zero debt. Essentially, the cash burn was almost $13 million over the past twelve months. With that, the company had only 19 months of cash runway. The worrying part is that if the company runs out of cash, and that too in the middle of a pandemic. 

Check-cap is still in its early days and is developing as a business. The increase in cash burn shows that the company is focused on future growth and its current focus on its C-Scan pivotal study. 

Conclusion

Wall Street is positive on Check-Cap Ltd. (CHEK) and expects medical diagnostics to grow in the long-term. The game will change once the company receives the guidance update from the FDA on IDE. However, analysts’ rate CHEK stock as a strong buy. The average price target is around $1.7, with an upside of 32% over the next 12 months.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Onesmart International Education Group Ltd. (ONE) stock surges during current market. What’s driving it high?

Onesmart International Education Group Ltd. (NASDAQ: ONE) stock gains by 111.86% in the current market trading session. OneSmart International Education is a major Chinese...

LivePerson Inc. (LPSN) stock plunge during pre-market. What’s driving it low?

LivePerson Inc. (NASDAQ: LPSN) stock gained by 0.86% at last close whereas the LPSN stock declines by 9.39% in the pre-market trading session. Through...

The Clorox Company Ltd. (CLX) stock decline during pre-market. Here’s the recent update

The Clorox Company Ltd. (NASDAQ: CLX) stock gained by 0.17% at last close whereas the CLX stock price fell by 11.59% in the pre-market....

IT Tech Packaging Inc. (ITP) stock gains during pre-market. Here’s what’s happening?

IT Tech Packaging Inc. (NASDAQ: ITP) stock gained by 7.53% at last close while the ITP stock price rises by 2.04% in the pre-market...

Why did The9 Limited (NCTY) stock turnaround in the after-hours on Friday?

The9 Limited (NCTY) shares gained 6.87% in after-hours on Friday, July 30, 2021, and closed the weekly trading at $11.98 per share. in the...

Why did Scopus BioPharma Inc. (SCPS) stock couldn’t keep its positivity in the after-hours on Wednesday?

Scopus BioPharma Inc. (SCPS) shares plunged 8.40% in after-hours on Wednesday, August 04, 2021, and closed the daily trading at $5.56 per share. earlier...

Why did Etsy Inc. (ETSY) shares decline in the after-markets on Wednesday?

Etsy Inc. (ETSY) shares declined 13.81% in after-hours on Wednesday, August 04, 2021, and closed the daily trading at $174.20 per share. In the...

Here is why MicroVision Inc. (MVIS) stock surged in the after-hours on Wednesday?

MicroVision Inc. (MVIS) shares surged 14.98% in after-hours on Wednesday, August 04, 2021, and closed the daily trading at $14.05 per share. In the...

Related News

Why did Scopus BioPharma Inc. (SCPS) stock couldn’t keep its positivity in the after-hours on Wednesday?

Scopus BioPharma Inc. (SCPS) shares plunged 8.40% in after-hours on Wednesday, August 04, 2021, and closed the daily trading at $5.56 per share. earlier...

Why did Etsy Inc. (ETSY) shares decline in the after-markets on Wednesday?

Etsy Inc. (ETSY) shares declined 13.81% in after-hours on Wednesday, August 04, 2021, and closed the daily trading at $174.20 per share. In the...

Here is why MicroVision Inc. (MVIS) stock surged in the after-hours on Wednesday?

MicroVision Inc. (MVIS) shares surged 14.98% in after-hours on Wednesday, August 04, 2021, and closed the daily trading at $14.05 per share. In the...

Here is why Activision Blizzard Inc. (ATVI) stock turnaround in the after-hours on Tuesday?

Activision Blizzard Inc. (ATVI) shares gained 6.10% in after-hours on Tuesday, August 03, 2021, and closed the daily trading at $84.70 per share. Earlier...

Lixte Biotechnology Holdings Inc. (LIXT) stock surge during current market. Here’s the recent news

Lixte Biotechnology Holdings Inc. (NASDAQ: LIXT) stock gains by 32.32% in the current market trading session. Lixte Biotechnology Holdings is a clinical-stage pharmaceutical business...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam